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Rationale
There are little data on the role of tryptase in the diagnosis
of anaphylaxis. We aimed to assess the sensitivity of
elevated tryptase levels (>11.4) as defined in the current
medical literature to diagnose anaphylaxis and to identify
factors associated with elevated tryptase levels.
Methods
Children presenting with anaphylaxis to the Montreal
Children’s Hospital Emergency Department (ED) between
April 2011 and April 2013 were recruited. The treating
physician documented symptoms, triggers, and manage-
ment of the anaphylactic reactions. Total tryptase levels
were measured 30-120 minutes following onset of
symptoms. Charts of all ED patients were reviewed to
identify cases that were missed in prospective recruitment.
Multivariate logistic regression was used to examine the
association between an elevated tryptase level and age,
gender, reaction trigger, reaction severity, and history of
atopy.
Results
Of 398 anaphylaxis cases (203 of whom were recruited
prospectively), 84 children had serum tryptase levels
measured. Age, gender, anaphylactic trigger, and severity
of reaction were comparable between cases with and
without tryptase measurements. However, there was
higher percentage of patients treated with epinephrine in
hospital in the group with tryptase measurements. The
median age of these 84 children was 5.1 years (IQR 1.3,
12.3), 40.4% were females, 78.6% identified food as the
potential anaphylactic trigger, and 7.1% experienced
a severe reaction.. The mean tryptase level was 6.9 ng/mL
(4.5, 8.0). Only 13 patients [15.5% (95%CI, 8.8,25.4)] had
elevated levels. Severe reactions and history of eczema
were associated with elevated levels ( OR =115.4 (95%
CI,8.7,1527.8) and 14.2(95%CI,2.6,78.5) respectively.
Conclusions
Our results do not support the use of total tryptase as a
diagnostic tool in children with anaphylaxis. Given the
poor sensitivity (13/84 = 15%) of the current tryptase
threshold, new laboratory tests need to be developed to
help establish the diagnose of anaphylaxis accurately.
Severe reactions and presence of eczema are associated
with high levels, but wide confidence intervals preclude
definitive conclusions for the other risk factors we
investigated.
Authors’ details
1Division of Paediatric Allergy and Clinical Immunology, Department of
Paediatrics, McGill University Health Centre, Montreal, Quebec, Canada.
2Division of Clinical Epidemiology, Department of Medicine, McGill University
Health Centre, Montreal, Quebec, Canada. 3Division of Allergy and Clinical
Immunology, Department of Medicine, McGill University Health Centre,
Montreal, Quebec, Canada. 4Food Directorate, Health Canada, Ottawa,
Ontario, Canada. 5Montreal Children’s Hospital, Emergency Department,
McGill University Health Centre, Montreal, Quebec, Canada. 6Departments of
Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada.
7Department of Emergency Medicine, Hôpital du Sacré-Coeur de Montréal,
Université de Montréal, Québec, Canada.
Published: 3 March 2014
doi:10.1186/1710-1492-10-S1-A66
Cite this article as: Halbrich et al.: Tryptase levels in children presenting
with anaphylaxis to the Montreal Children’s Hospital. Allergy, Asthma &
Clinical Immunology 2014 10(Suppl 1):A66.
* Correspondence: michelle.halbrich@hotmail.com
1Division of Paediatric Allergy and Clinical Immunology, Department of
Paediatrics, McGill University Health Centre, Montreal, Quebec, Canada
Full list of author information is available at the end of the article
Halbrich et al. Allergy, Asthma & Clinical Immunology 2014, 10(Suppl 1):A66
http://www.aacijournal.com/content/10/S1/A66 ALLERGY, ASTHMA & CLINICAL 
IMMUNOLOGY
© 2014 Halbrich et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
